Cytori Gains Stem Cell Device Approval In Europe For Breast Cancer Reconstruction And

[News]

Cytori Therapeutics (NASDAQ: CYTX) received expanded European approval (CE Mark) for its Celution® System, a medical device that extracts and separates stem and regenerative cells from a patient's own fat tissue...

More... (http://mnt.to/f/3GHC)